Activator protein 1 (AP-1)– and nuclear factor κB (NF-κB)–dependent transcriptional events in carcinogenesis

[1]  N. Colburn,et al.  cDNA cloning and mapping of mouse pleckstrin (Plek), a gene upregulated in transformation-resistant cells. , 2000, Genomics.

[2]  L. Bernstein,et al.  Tumor promotion resistant cells are deficient in AP-1 DNA binding, JunD DNA binding and JunD expression and form different AP-1-DNA complexes than promotion sensitive cells. , 1999, Biochimica et biophysica acta.

[3]  N. Colburn,et al.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Weiya Ma,et al.  JNK Activation Is Required for JB6 Cell Transformation Induced by Tumor Necrosis Factor-α but Not by 12-O-Tetradecanoylphorbol-13-Acetate* , 1999, The Journal of Biological Chemistry.

[5]  N. Colburn,et al.  Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation , 1999, Oncogene.

[6]  P. D. Dal Cin,et al.  HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. , 1999, Advances in anatomic pathology.

[7]  L. Ignarro,et al.  Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. , 1999, Biochemical and biophysical research communications.

[8]  N. Colburn,et al.  Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Michael Karin,et al.  Is NF‐κB the sensor of oxidative stress? , 1999 .

[10]  C. Hunt,et al.  Redox Factor-1 (Ref-1) Mediates the Activation of AP-1 in HeLa and NIH 3T3 Cells in Response to Heat Shock* , 1999, The Journal of Biological Chemistry.

[11]  D. Gius,et al.  Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1. , 1999, Toxicology letters.

[12]  Weiya Ma,et al.  The extracellular-signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cells , 1999, Oncogene.

[13]  I. Macara,et al.  Cooperativity between Oxidants and Tumor Necrosis Factor in the Activation of Nuclear Factor (NF)- κ B , 1999 .

[14]  A. Beyerle,et al.  UVB activates ERK1/2 and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. , 1999, The Journal of investigative dermatology.

[15]  N. Colburn,et al.  Specific methylation events contribute to the transcriptional repression of the mouse tissue inhibitor of metalloproteinases-3 gene in neoplastic cells. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  R. Reeves,et al.  High Mobility Group-I(Y) Protein Facilitates Nuclear Factor-κB Binding and Transactivation of the Inducible Nitric-oxide Synthase Promoter/Enhancer* , 1999, The Journal of Biological Chemistry.

[17]  T. Slaga,et al.  Tumor promoter benzoyl peroxide induces sulfhydryl oxidation in protein kinase C: its reversibility is related to the cellular resistance to peroxide-induced cytotoxicity. , 1999, Archives of biochemistry and biophysics.

[18]  A. Puga,et al.  Regulation of gene expression by reactive oxygen. , 1999, Annual review of pharmacology and toxicology.

[19]  Z. Dong,et al.  Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation , 1998, Oncogene.

[20]  N. Colburn,et al.  Inhibition of AP‐1 and NF‐κB by manganese‐containing superoxide dismutase in human breast cancer cells , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  R. Whisler,et al.  Transcriptional Activation and Redox Regulation of the Tumor Necrosis Factor-α Promoter in Human T Cells: Role of the CRE/κ3 Promoter Region , 1998 .

[22]  M. Ginn-Pease,et al.  Redox Signals and NF-κB Activation in T Cells , 1998 .

[23]  N. Colburn,et al.  Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells , 1998, Oncogene.

[24]  N. Colburn,et al.  Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes , 1998, Oncogene.

[25]  Tao Yan,et al.  Overexpression of Manganese Superoxide Dismutase Suppresses Tumor Necrosis Factor-induced Apoptosis and Activation of Nuclear Transcription Factor-κB and Activated Protein-1* , 1998, The Journal of Biological Chemistry.

[26]  N. Colburn,et al.  Maspin gene expression in tumor suppression induced by overexpressing manganese-containing superoxide dismutase cDNA in human breast cancer cells. , 1998, Carcinogenesis.

[27]  M. Drutskaya,et al.  The N-Terminal Domain of IκBα Masks the Nuclear Localization Signal(s) of p50 and c-Rel Homodimers , 1998, Molecular and Cellular Biology.

[28]  M. Grisham,et al.  Differential regulation of extracellular signal-regulated kinase and nuclear factor-kappa B signal transduction pathways by hydrogen peroxide and tumor necrosis factor. , 1998, Archives of biochemistry and biophysics.

[29]  I. Eto.  Promotion‐sensitive epidermal and mammary epithelial cells maintained in suspension over agarose , 1998, Cell proliferation.

[30]  Weiya Ma,et al.  Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Lemmon,et al.  Pleckstrin homology domains. , 1998, Current topics in microbiology and immunology.

[32]  A. E. Rogers,et al.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.

[33]  K. Jeang,et al.  Regulatory Role for a Novel Human Thioredoxin Peroxidase in NF-κB Activation* , 1997, The Journal of Biological Chemistry.

[34]  T. Kensler,et al.  Redox regulation of genes that protect against carcinogens. , 1997, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[35]  G. Powis,et al.  Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. , 1997, Cancer research.

[36]  M. P. Miano,et al.  Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression , 1997, Oncogene.

[37]  A. Bowie,et al.  Lipid Peroxidation Is Involved in the Activation of NF-κB by Tumor Necrosis Factor but Not Interleukin-1 in the Human Endothelial Cell Line ECV304 , 1997, The Journal of Biological Chemistry.

[38]  B. Trump,et al.  bcl‐2 enhancement of malignant transformation in mouse epidermal JB6 cells , 1997, Molecular carcinogenesis.

[39]  C. Der,et al.  Oncogenic Ha-Ras-induced Signaling Activates NF-κB Transcriptional Activity, Which Is Required for Cellular Transformation* , 1997, The Journal of Biological Chemistry.

[40]  N. Colburn,et al.  Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. , 1997, Cancer research.

[41]  B. Ames,et al.  Oxidative Decay of DNA* , 1997, The Journal of Biological Chemistry.

[42]  Z. Dong,et al.  Promotion-resistant JB6 mouse epidermal cells exhibit defects in phosphatidylethanolamine synthesis and phorbol ester-induced phosphatidylcholine hydrolysis. , 1997, The Biochemical journal.

[43]  K. Mori,et al.  AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Céline Gélinas,et al.  Rel/NF-?B and I?B factors in oncogenesis , 1997 .

[45]  L. Oberley,et al.  Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. , 1997, Human gene therapy.

[46]  P. Baeuerle,et al.  Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. , 1997, Methods.

[47]  B. Trump,et al.  Manganese superoxide dismutase expression inhibits soft agar growth in JB6 clone41 mouse epidermal cells. , 1997, Carcinogenesis.

[48]  Weiya Ma,et al.  Phosphatidylinositol-3 Kinase Is Necessary for 12-O-Tetradecanoylphorbol-13-acetate-induced Cell Transformation and Activated Protein 1 Activation* , 1997, The Journal of Biological Chemistry.

[49]  N. Colburn,et al.  Use of Mouse JB6 Cells to Identify Molecular Targets and Novel Agents for Prevention of Carcinogenesis , 1997 .

[50]  T. Kensler,et al.  Antioxidant-inducible genes. , 1997, Advances in pharmacology.

[51]  H. Nakamura,et al.  Redox regulation of cellular activation. , 1997, Annual review of immunology.

[52]  P J Barnes,et al.  Nuclear Factor-kappa B , 2006 .

[53]  T. Russo,et al.  Gene regulation by reactive oxygen species. , 1997, Current topics in cellular regulation.

[54]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[55]  H. Kizaki,et al.  Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. , 1996, Biochemical and biophysical research communications.

[56]  Weiya Ma,et al.  Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells , 1996, Molecular and cellular biology.

[57]  D. White,et al.  Rel/NF-kappaB/IkappaB proteins and cancer. , 1996, Oncogene.

[58]  M. Moroni,et al.  Antioxidant enzymatic system and free radicals pathway in two different human cancer cell lines. , 1996, Anticancer research.

[59]  J. Wispé,et al.  Redox regulation of manganese superoxide dismutase. , 1996, The American journal of physiology.

[60]  R. Pinkus,et al.  Role of Oxidants and Antioxidants in the Induction of AP-1, NF-κB, and Glutathione S-Transferase Gene Expression* , 1996, The Journal of Biological Chemistry.

[61]  P. Mehlen,et al.  Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression , 1996, The Journal of cell biology.

[62]  C. Sen,et al.  Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[63]  J. Mergny,et al.  Ultraviolet‐A induces activation of AP‐1 in cultured human keratinocytes , 1996, FEBS letters.

[64]  T. Osawa,et al.  International Conference on food factors: Chemistry and cancer prevention☆ , 1996 .

[65]  Z. Dong,et al.  Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. , 1996, Cancer research.

[66]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[67]  P. Cerutti,et al.  Identification of hydrogen peroxide as the relevant messenger in the activation pathway of transcription factor NF-kappaB. , 1996, Advances in experimental medicine and biology.

[68]  H. Pahl,et al.  Reactive oxygen intermediates as second messengers of a general pathogen response. , 1996, Pathologie-biologie.

[69]  T. Honjo,et al.  Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. , 1995, Gene.

[70]  P. Baeuerle,et al.  The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B. , 1995, European journal of biochemistry.

[71]  R. Reeves,et al.  Characterization of transgenic mice with an increased content of chromosomal protein HMG-14 in their chromatin. , 1995, DNA and Cell Biology.

[72]  G. Powis,et al.  Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[73]  P. Baeuerle,et al.  Induction of Oxidative Stress by Okadaic Acid Is Required for Activation of Transcription Factor NF-κB (*) , 1995, The Journal of Biological Chemistry.

[74]  K. Teng,et al.  p21ras as a Common Signaling Target of Reactive Free Radicals and Cellular Redox Stress (*) , 1995, The Journal of Biological Chemistry.

[75]  N. Colburn,et al.  Molecular Cloning of Mouse Tissue Inhibitor of Metalloproteinases-3 and Its Promoter , 1995, The Journal of Biological Chemistry.

[76]  P. Chang,et al.  Effects of Okadaic Acid on Calcitriol‐and Phorbol Ester‐Induced Expression and Phosphorylation of Osteopontin in Mouse JB6 Epidermal Cells a , 1995, Annals of the New York Academy of Sciences.

[77]  M. Karin.  The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.

[78]  Neeta Singh,et al.  The effect of active oxygen generated by xanthine/xanthine oxidase on genes and signal transduction in mouse epidermal JB6 cells , 1995, International journal of cancer.

[79]  R. Reeves,et al.  Differential Regulation of a Multipromoter Gene. , 1995, The Journal of Biological Chemistry.

[80]  L. Su,et al.  Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. , 1995, Oncogene.

[81]  L. Packer,et al.  Transient Overexpression of Catalase Does Not Inhibit TNF- or PMA-Induced NF-κB Activation , 1995 .

[82]  N. Colburn,et al.  c‐jun and multistage carcinogenesis: Association of overexpression of introduced c‐jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter‐induced transformation , 1995, Molecular carcinogenesis.

[83]  L. O’Neill,et al.  Effects of oxidants and antioxidants on nuclear factor kappa B activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. , 1995, Biochimica et biophysica acta.

[84]  K. Schulze-Osthoff,et al.  Hydrogen peroxide as a potent activator of T lymphocyte functions , 1995, European journal of immunology.

[85]  N. Colburn,et al.  C-JUN/AP-1 as possible mediators of tumor necrosis factor-alpha-induced apoptotic response in mouse JB6 tumor cells. , 1995, Oncology research.

[86]  L. Packer,et al.  Signal transduction for nuclear factor-kappa B activation. Proposed location of antioxidant-inhibitable step. , 1994, Journal of immunology.

[87]  D. Hamernik,et al.  Analysis of transcriptional activation of a cyclic AMP response element by 2,6,10,14‐tetramethylpentadecane (pristane) in JB6 mouse epidermal cells , 1994, Molecular carcinogenesis.

[88]  P. Cerutti,et al.  The role of the cellular antioxidant defense in oxidant carcinogenesis. , 1994, Environmental health perspectives.

[89]  F. Staal,et al.  Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[90]  P. Cerutti,et al.  Differential cytotoxicity in mouse epidermal JB6 cells: A potential mechanism for oxidant tumor promotion , 1994, Molecular carcinogenesis.

[91]  N. Sonenberg,et al.  Disruption of I kappa B alpha regulation by antisense RNA expression leads to malignant transformation. , 1994, Oncogene.

[92]  N. Colburn,et al.  Preferential primary‐response gene expression in promotion‐resistant versus promotion‐sensitive JB6 cells , 1994, Molecular carcinogenesis.

[93]  M. Karin,et al.  c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK , 1994, Nature.

[94]  P. Chang,et al.  Calcitriol regulation of osteopontin expression in mouse epidermal cells. , 1994, Endocrinology.

[95]  H. Pahl,et al.  Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. , 1994, Chemico-biological interactions.

[96]  K. Struhl,et al.  The UV response involving the ras signaling pathway and AP-1 transcription factors is conserved between yeast and mammals , 1994, Cell.

[97]  N. Colburn,et al.  A family of mitogen-activated protein kinase-related proteins interacts in vivo with activator protein-1 transcription factor. , 1994, The Journal of biological chemistry.

[98]  W. Dröge,et al.  Effect of glutathione depletion and oral N‐acetyl‐cysteine treatment on CD4+ and CD8+ cells , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[99]  K. Schulze-Osthoff,et al.  Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[100]  N. Colburn,et al.  Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3. , 1994, Cancer research.

[101]  Z. Dong,et al.  Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[102]  K. Schulze-Osthoff,et al.  転写因子NF‐κBとAP‐1の活性化に及ぼすチオレドキシンと抗酸化剤の異なった効果 , 1994 .

[103]  D. Forrest,et al.  Differential roles for Fos and Jun in DNA-binding: redox-dependent and independent functions. , 1993, Nucleic acids research.

[104]  T. Coleman,et al.  Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[105]  M. Karin,et al.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.

[106]  W. Greene,et al.  Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. , 1993, The EMBO journal.

[107]  M. Karin,et al.  NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. , 1993, Science.

[108]  N. Colburn,et al.  Depression of catalase gene expression after immortalization and transformation of mouse liver cells. , 1993, Carcinogenesis.

[109]  P. Baeuerle,et al.  H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor. , 1993, The EMBO journal.

[110]  Timothy N. C. Wells,et al.  Role of cysteine62 in DNA recognition by the P50 subunit of NF-xB , 1993 .

[111]  N. Heintz,et al.  Persistent induction of c-fos and c-jun expression by asbestos. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[112]  N. Colburn,et al.  Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[113]  P. Meltzer,et al.  Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[114]  Andrew J. Bannister,et al.  c-Jun is phosphorylated by the DNA-dependent protein kinase in vitro; definition of the minimal kinase recognition motif. , 1993, Nucleic acids research.

[115]  H. Iba,et al.  Escape from redox regulation enhances the transforming activity of Fos. , 1993, Oncogene.

[116]  Trump Bf,et al.  INFLAMMATION AND OXIDATIVE STRESS IN CARCINOGENESIS , 1993 .

[117]  T. Galeotti,et al.  Defective gene expression of MnSOD in cancer cells. , 1993, Molecular aspects of medicine.

[118]  N. Colburn,et al.  Decreased expression of manganese superoxide dismutase mRNA and protein after immortalization and transformation of mouse liver cells. , 1993, Oncology research.

[119]  C. Rice-Evans,et al.  Reduction of a tetrazolium salt and superoxide generation in human tumor cells (HeLa). , 1993, Free radical research communications.

[120]  P. Cerutti,et al.  Oxidant Carcinogenesis and Antioxidant Defense a , 1992, Annals of the New York Academy of Sciences.

[121]  T. Curran.  Fos and Jun: oncogenic transcription factors. , 1992, The Tohoku journal of experimental medicine.

[122]  C. Baxter,et al.  Carba-prostacyclin inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced transformation in sensitive murine epidermal JB6 cells. , 1992, Carcinogenesis.

[123]  T. Curran,et al.  Redox activation of Fos‐Jun DNA binding activity is mediated by a DNA repair enzyme. , 1992, The EMBO journal.

[124]  J. Yodoi,et al.  Thiordoxin regulates the DNA binding activity of NF-χB by reduction of a disulphid bond involving cysteine 62 , 1992 .

[125]  P. Cerutti,et al.  Mechanism of c-fos induction by active oxygen. , 1992, Cancer research.

[126]  D. Nebert,et al.  Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. , 1992, DNA and cell biology.

[127]  D. Forrest,et al.  Crossed signals: oncogenic transcription factors , 1992, Current Biology.

[128]  C. Baxter,et al.  JB6 murine epidermal cell lines sensitive and resistant to 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced transformation exhibit differential arachidonic acid metabolism in response to TPA and the calcium ionophore A23187. , 1992, Carcinogenesis.

[129]  T. Curran,et al.  Identification and characterization of Ref‐1, a nuclear protein that facilitates AP‐1 DNA‐binding activity. , 1992, The EMBO journal.

[130]  A. Bloom,et al.  Biological consequences of oxidative stress : implications for cardiovascular disease and carcinogenesis , 1992 .

[131]  N. Colburn,et al.  Differential induction of 15 and 16 kDa nuclear proteins in promotion sensitive and promotion resistant mouse JB6 cells. , 1992, Oncology Research.

[132]  J. Melendez,et al.  Reduced expression of manganese superoxide dismutase in cells resistant to cytolysis by tumor necrosis factor. , 1992, Free radical biology & medicine.

[133]  K. Albermann,et al.  Nuclear Factor Kb: An Oxidative Stress-Responsive Transcription Factor of Eukaryotic Cells (A Review) , 1992 .

[134]  N. Colburn,et al.  12‐O‐tetradecanoylphorbol‐13‐acetate—induced levels of ap‐1 proteins: a 46‐kda protein immunoprecipitated by anti‐fra‐1 and induced in promotion‐resistant but not promotion‐sensitive JB6 cells , 1992, Molecular carcinogenesis.

[135]  N. Colburn,et al.  Differential c‐jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation , 1992, Molecular carcinogenesis.

[136]  R. Floyd.  Oxidative damage to behavior during aging. , 1991, Science.

[137]  N. Taniguchi,et al.  Phorbol ester induces manganese-superoxide dismutase in tumor necrosis factor-resistant cells. , 1991, The Journal of biological chemistry.

[138]  P. Cerutti,et al.  The balance between copper-zinc superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress , 1991 .

[139]  N. Colburn,et al.  Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells. , 1991, Environmental health perspectives.

[140]  W. Leonard,et al.  Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[141]  M. Karin,et al.  Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain , 1991, Nature.

[142]  M. Karin,et al.  Rapid and preferential activation of the c-jun gene during the mammalian UV response , 1991, Molecular and cellular biology.

[143]  Tony Hunter,et al.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.

[144]  P. Cerutti,et al.  Oxidant stress and carcinogenesis , 1991, European journal of clinical investigation.

[145]  T. Curran,et al.  Redox regulation of fos and jun DNA-binding activity in vitro. , 1990, Science.

[146]  C. Deby,et al.  New perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases. , 1990, Biochemical pharmacology.

[147]  C. Rice-Evans,et al.  Oxidative stress and tumour cell proliferation. , 1990, Free radical research communications.

[148]  B. Halliwell.  How to characterize a biological antioxidant. , 1990, Free radical research communications.

[149]  Y. Sun,et al.  Free radicals, antioxidant enzymes, and carcinogenesis. , 1990, Free radical biology & medicine.

[150]  P. Herrlich,et al.  UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein , 1989, Molecular and cellular biology.

[151]  N. Colburn,et al.  Differential expression of an 80-kDa protein kinase C substrate in preneoplastic and neoplastic mouse JB6 cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[152]  A. Craig,et al.  Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. , 1989, The Journal of biological chemistry.

[153]  C. Harley,et al.  Molecular analysis of pleckstrin: The major protein kinase c substrate of platelets , 1989, Journal of cellular biochemistry.

[154]  N. Colburn,et al.  AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. , 1989, Science.

[155]  P. Cerutti,et al.  Constitutive and phorbol‐myristate‐acetate regulated antioxidant defense of mouse epidermal JB6 cells , 1989, Molecular carcinogenesis.

[156]  N. Colburn,et al.  Comparison of mouse pro-1 and pro-2 transfectants for responses to tumor promoters and antipromoters. , 1988, Cancer research.

[157]  M. Karin,et al.  Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. , 1988, Oncogene.

[158]  N. Colburn,et al.  Protein kinase C and its substrates in tumor promoter-sensitive and -resistant cells. , 1988, The Journal of biological chemistry.

[159]  T. Hunter,et al.  Oncogene jun encodes a sequence-specific trans- activator similar to AP-1 , 1988, Nature.

[160]  N. Colburn,et al.  Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells. , 1988, Carcinogenesis.

[161]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[162]  N. Colburn,et al.  Genes that cooperate with tumor promoters in transformation , 1987, Journal of cellular biochemistry.

[163]  D. Denhardt,et al.  Molecular cloning of a tumor promoter‐inducible mRNA found in JB6 mouse epidermal cells: Induction is stable at high, but not at low, cell densities , 1987, Journal of cellular biochemistry.

[164]  S. Weitzman,et al.  Phagocytes as carcinogens: malignant transformation produced by human neutrophils. , 1985, Science.

[165]  N. Colburn,et al.  Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA. , 1985, Carcinogenesis.

[166]  P. Cerutti.  Prooxidant states and tumor promotion. , 1985, Science.

[167]  J. Theodore,et al.  Differences in oxygen‐dependent regulation of enzymes between tumor and normal cell systems in culture , 1981, Journal of cellular physiology.

[168]  I. Fridovich.  Superoxide dismutases: defence against endogenous superoxide radical. , 2008, Ciba Foundation symposium.

[169]  I. Fridovich.  Oxygen free radicals and tissue damage: chairman's introduction. , 1978, Ciba Foundation symposium.